查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1815506

2025年免疫血液學全球市場報告

Immunohematology Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

預計未來幾年免疫血液學市場將強勁成長，到2029年將達到31.7億美元，複合年成長率為5.7%。預測期內的成長可歸因於就地檢驗需求的不斷成長、新型血液製品的出現、醫療保健基礎設施的不斷擴展、血液相容性基因檢測以及血液安全監管支持。預測期內的主要趨勢包括自動化和高通量系統、分子血型分型、抗體檢測技術、患者血液管理方案、人工智慧與分析技術的整合以及遠端醫療的整合。

未來五年5.7%的成長預測比我們先前對該市場的預測略有下降，下降了0.2%。下降的主要原因是美國與其他國家之間的關稅影響。預計關稅壁壘將擾亂美國醫院血庫的營運，導致來自美國和法國的自動紅血球配型系統和單克隆抗血清試劑成本上升，輸血產品的準備時間延長，血液病理學檢測服務成本上升。由於互惠關稅以及貿易緊張局勢和限制加劇對全球經濟和貿易的負面影響，關稅壁壘的影響也將更加廣泛。

預計血液疾病盛行率的上升將在短期內推動免疫血液學市場的成長。影響紅血球、白血球、血小板和血漿等血液成分的血液疾病需要使用免疫血液學技術進行安全有效的輸血。這可以防止因血型不合或受血者血液中存在抗體而引起的輸血反應。免疫血液學技術在影響免疫系統的疾病的診斷和治療中也發揮關鍵作用，這些疾病也可能影響血液系統。例如，英國癌症研究中心報告稱，英國因血液疾病引起的白血病新病例數預計將從2023-2025年的約12,400例增加到2038-2040年的約14,500例。因此，血液疾病盛行率的上升是支持免疫血液學市場成長的關鍵因素。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第4章 市場：宏觀經濟情景，包括利率、通膨、地緣政治、貿易戰和關稅，以及新冠疫情和復甦對市場的影響

第5章 全球成長分析與策略分析框架

  • 全球免疫血液學：PESTEL 分析（政治、社會、技術、環境、法律因素、促進因素和限制因素）
  • 最終用途產業分析
  • 全球免疫血液學市場：成長率分析
  • 全球免疫血液學市場表現：規模與成長，2019-2024
  • 全球免疫血液學市場預測：規模與成長，2024-2029 年，2034 年
  • 全球免疫血液學：總目標市場（TAM）

第6章 市場細分

  • 全球免疫血液學市場：依產品、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 分析儀器和系統
  • 試劑
  • 全球免疫血液學市場：依技術、績效與預測，2019-2024 年、2024-2029 年、2034 年
  • 生物晶片
  • 紅血球磁化技術（Met）
  • 凝膠卡
  • 微孔盤
  • 聚合酵素鏈鎖反應（PCR）
  • 全球免疫血液學市場：按疾病、表現和預測，2019-2024 年、2024-2029 年、2034 年
  • 血液相關疾病
  • HIV
  • 肝炎
  • 全球免疫血液學市場：依應用、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 輸血前檢測
  • 免疫溶血的調查
  • 周產期檢查
  • 血型表現型
  • 白血球和血小板血清學檢查
  • 全球免疫血液學市場：按最終用戶、實際和預測，2019-2024 年、2024-2029 年、2034 年
  • 血庫
  • 診斷與參考實驗室
  • 醫院
  • 學術研究機構
  • 全球免疫血液學市場：按分析儀器和系統細分（按類型）、實際和預測，2019-2024 年、2024-2029 年、2034 年
  • 血型分析儀
  • 交叉試驗分析儀
  • 凝膠卡系統
  • 全球免疫血液學市場：按試劑類型、性能和預測細分，2019-2024 年、2024-2029 年、2034 年
  • 血型試劑
  • 抗血清
  • 對照血清

第7章 區域和國家分析

  • 全球免疫血液學市場：區域分析、預測與趨勢，2019-2024 年、2024-2029 年、2034 年
  • 全球免疫血液學市場：國家、績效及預測（2019-2024 年、2024-2029 年及 2034 年）

第8章 亞太市場

第9章：中國市場

第10章 印度市場

第11章 日本市場

第12章：澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章 西歐市場

第16章英國市場

第17章：德國市場

第18章：法國市場

第19章：義大利市場

第20章：西班牙市場

第21章 東歐市場

第22章俄羅斯市場

第23章 北美市場

第24章美國市場

第25章：加拿大市場

第26章 南美洲市場

第27章：巴西市場

第28章 中東市場

第29章：非洲市場

第30章：競爭格局與公司概況

  • 免疫血液學市場：競爭格局
  • 免疫血液學市場：公司簡介
    • Ortho Clinical Diagnostics Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Immunocor Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis
    • Grifols SA Overview, Products and Services, Strategy and Financial Analysis

第31章：其他領先和創新企業

  • Beckman Coulter Inc.
  • Thermo Fisher Scientific Inc.
  • Becton Dickinson and Company
  • Merck Co. & KGaA
  • Bio-Rad Laboratories
  • Sysmex Corporation
  • Danaher Corporation
  • Biosystems SA
  • Roche Holdings AG
  • Mindray Medical International Limited
  • F.Hoffmann La-Roche Ltd.
  • Biotest AG
  • Cardinal Health Inc.
  • Quotient Limited
  • DiaSorin SpA

第 32 章全球市場競爭基準化分析與儀表板

第33章 重大併購

第34章近期市場趨勢

第 35 章：高潛力市場國家、細分市場與策略

  • 2029年免疫血液學市場：提供新機會的國家
  • 2029年免疫血液學市場：細分領域帶來新機會
  • 2029年免疫血液學市場：成長策略
    • 基於市場趨勢的策略
    • 競爭對手策略

第36章 附錄

簡介目錄
Product Code: r24221u

Immunohematology is a subfield of laboratory medicine that focuses on the study of blood groups and the immune response of the body to foreign substances, particularly in the context of blood transfusions. Immunohematological techniques are employed to identify and address diagnostic issues in patients with hematological conditions, including auto-immune hemolytic anemia.

The main components of immunohematology include analyzers and systems, along with reagents. Analyzers and systems are automated instruments designed for blood typing and antibody screening. Various technologies are utilized in this field, such as biochips, erythrocyte-magnetized technology (EMT), gel cards, microplates, and polymerase chain reaction (PCR). These technologies are applied in the treatment of various diseases such as HIV and hepatitis. The diverse applications encompass pretransfusion testing, investigation of immune hemolysis, perinatal testing, blood group phenotyping, leucocyte and platelet serology. The end-users of immunohematology products include blood banks, diagnostic and reference laboratories, hospitals, as well as academic and research institutes.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sudden escalation of U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the pharmaceutical sector. Companies are grappling with higher costs on imported active pharmaceutical ingredients (APIs), glass vials, and laboratory equipment-many of which have limited alternative sources. Generic drug manufacturers, already operating with minimal profit margins, are particularly affected, with some scaling back production of low-margin medications. Biotech firms are also experiencing delays in clinical trials due to shortages of specialized reagents linked to tariffs. In response, the industry is shifting API production to regions like India and Europe, building up inventory reserves, and advocating for tariff exemptions on essential medicines.

The immunohematology market research report is one of a series of new reports from The Business Research Company that provides immunohematology optical components market statistics, including immunohematology optical components industry global market size, regional shares, competitors with a immunohematology optical components market share, detailed immunohematology optical components market segments, market trends and opportunities, and any further data you may need to thrive in the immunohematology optical components industry. This immunohematology optical components market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The immunohematology market size has grown steadily in recent years. It will grow from $2.46 billion in 2024 to $2.55 billion in 2025 at a compound annual growth rate (CAGR) of 3.6%. The growth in the historic period can be attributed to advancements in blood transfusion science, the prevalence of blood disorders, the expansion of blood banks, government initiatives for blood safety, increased surgical procedures, and awareness of transfusion-related risks

The immunohematology market size is expected to see strong growth in the next few years. It will grow to $3.17 billion in 2029 at a compound annual growth rate (CAGR) of 5.7%. The growth in the forecast period can be attributed to increasing demand for point-of-care testing, emergence of novel blood products, expansion of healthcare infrastructure, genetic testing for blood compatibility, and regulatory support for blood safety. Major trends in the forecast period include automation and high-throughput systems, molecular blood typing methods, antibody detection techniques, patient blood management programs, integration of ai in analysis, telemedicine integration.

The forecast of 5.7% growth over the next five years reflects a modest reduction of 0.2% from the previous estimate for this market. This reduction is primarily due to the impact of tariffs between the US and other countries. Tariff barriers are expected to hamper U.S. hospital blood banks by increasing the cost of automated erythrocyte-matching systems and monoclonal antisera reagents sourced from South Korea and France, thereby prolonging transfusion preparation times and elevating hematopathology service costs. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The anticipated rise in the prevalence of hematological disorders is set to drive the growth of the immunohematology market in the foreseeable future. Hematological disorders, affecting blood components such as red blood cells, white blood cells, platelets, and plasma, necessitate the use of immunohematology for safe and effective blood transfusions. This helps prevent transfusion reactions arising from incompatible blood types or the presence of antibodies in the recipient's blood. Immunohematology techniques also play a crucial role in diagnosing and treating diseases impacting the immune system, with potential implications for the hematological system. For instance, Cancer Research UK reported an expected increase in new leukemia cases due to hematological disorders in the UK, rising from approximately 12,400 cases in 2023-2025 to around 14,500 cases in 2038-2040. Thus, the escalating prevalence of hematological disorders is a key driver behind the growth of the immunohematology market.

The growth of the immunohematology market is anticipated to be driven by the increasing aging population. An aging population refers to a demographic trend marked by a higher proportion of elderly individuals within a society. Immunohematology plays a crucial role in meeting the transfusion needs of this demographic, ensuring the safe use of blood products, and facilitating medical interventions for older adults. For instance, in January 2024, the Population Reference Bureau, a U.S.-based nonprofit organization, projected that the number of Americans aged 65 and older will rise from 58 million in 2022 to 82 million by 2050, representing a 47% increase. Additionally, this age group's share of the total population is expected to grow from 17% to 23% during the same period. Therefore, the aging population is a significant factor driving the expansion of the immunohematology market.

Leading companies in the immunohematology market are focused on creating innovative diagnostic solutions, such as soluble recombinant proteins that can mitigate the interference caused by the cancer therapy daratumumab. Soluble recombinant proteins are produced using recombinant DNA technology, maintaining their proper structure and functionality in a soluble form within a host cell or solution, making them suitable for research and therapeutic applications. For example, in November 2023, Grifols, S.A., a pharmaceutical company based in Spain, introduced the Grifols sCD38 solution. This product is the first-ever soluble recombinant protein developed specifically to address the interference that daratumumab causes in essential blood transfusion compatibility testing. Targeted at patients with multiple myeloma, this groundbreaking solution prevents daratumumab from binding to CD38 proteins on red blood cells, ensuring accurate pre-transfusion test results. By streamlining the processes of screening, identification, and crossmatching, Grifols sCD38 improves blood transfusion protocols and reduces delays in administering lifesaving transfusions.

Major companies operating in the immunohematology market are innovating by introducing new products such as self-sampling blood collection products to enhance their market profitability. Self-sampling blood collection involves individuals collecting their own blood samples for diagnostic purposes without the need for healthcare professionals. For example, in February 2023, Capitainer launched CapitainerB 50, a self-sampling blood collection device that protects samples from contamination. The microsampling technology employed ensures precise quantitative sampling comparable to conventional pipetting.

In March 2023, Werfen, S.A., a diagnostic care company based in Spain, completed the acquisition of Immucor Inc. for approximately $2 billion. This strategic move aimed to expand Werfen's capabilities in specialized diagnostic testing, particularly within diagnostic solutions. Immucor Inc., a transfusion diagnostics company based in Spain, focuses on providing safe, accessible, and affordable blood tests.

Major companies operating in the immunohematology market include Ortho Clinical Diagnostics Inc., Immunocor Inc., Abbott Laboratories, Siemens Healthineers AG, Grifols S.A., Beckman Coulter Inc., Thermo Fisher Scientific Inc., Becton Dickinson and Company, Merck Co. & KGaA, Bio-Rad Laboratories, Sysmex Corporation, Danaher Corporation, Biosystems S.A., Roche Holdings AG, Mindray Medical International Limited, F.Hoffmann La-Roche Ltd., Biotest AG, Cardinal Health Inc., Quotient Limited, DiaSorin S.p.A., Lorne Laboratories Ltd., Biokit S.A., Avox Technologies, Diagnostic Automation/Cortez Diagnostics Inc., Inno-train Diagnostik GmbH, Drucker Diagnostics Inc., Immundia Diagnostics Pvt. Ltd.

North America was the largest region in the immunohematology market in 2024. Asia-Pacific is expected to be the fastest growing region in the global immunohematology market during the forecast period. The regions covered in the immunohematology market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the immunohematology market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The immunohematology market includes revenues earned by entities by providing blood banking and transfusion medicine services. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Immunohematology Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on immunohematology market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for immunohematology ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The immunohematology market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Product: Analyzers And Systems; Reagents
  • 2) By Technology: Biochips; Erythrocyte-Magnetized Technology (Met); Gel Cards; Microplates; Polymerase Chain Reaction (PCR)
  • 3) By Disease: Blood-Related Diseases; HIV; Hepatitis
  • 4) By Application: Pretransfusion Testing; Investigation Of Immune Hemolysis; Perinatal Testing; Blood Group Phenotyping; Leucocyte And Platelet Serology
  • 5) By End User: Blood Banks; Diagnostic And Reference Laboratories; Hospitals; Academic And Research Institutes
  • Subsegments:
  • 1) By Analyzers And Systems: Blood Typing Analyzers; Cross-Matching Analyzers; Gel Card Systems
  • 2) By Reagents: Blood Grouping Reagents; Antisera; Control Serum
  • Companies Mentioned: Ortho Clinical Diagnostics Inc.; Immunocor Inc.; Abbott Laboratories; Siemens Healthineers AG; Grifols S.A.; Beckman Coulter Inc.; Thermo Fisher Scientific Inc.; Becton Dickinson and Company; Merck Co. & KGaA; Bio-Rad Laboratories; Sysmex Corporation; Danaher Corporation; Biosystems S.A.; Roche Holdings AG; Mindray Medical International Limited; F.Hoffmann La-Roche Ltd.; Biotest AG; Cardinal Health Inc.; Quotient Limited; DiaSorin S.p.A.; Lorne Laboratories Ltd.; Biokit S.A.; Avox Technologies; Diagnostic Automation/Cortez Diagnostics Inc.; Inno-train Diagnostik GmbH; Drucker Diagnostics Inc.; Immundia Diagnostics Pvt. Ltd.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Immunohematology Market Characteristics

3. Immunohematology Market Trends And Strategies

4. Immunohematology Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Immunohematology Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Immunohematology PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Immunohematology Market Growth Rate Analysis
  • 5.4. Global Immunohematology Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Immunohematology Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Immunohematology Total Addressable Market (TAM)

6. Immunohematology Market Segmentation

  • 6.1. Global Immunohematology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Analyzers And Systems
  • Reagents
  • 6.2. Global Immunohematology Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Biochips
  • Erythrocyte-Magnetized Technology (Met)
  • Gel Cards
  • Microplates
  • Polymerase Chain Reaction (PCR)
  • 6.3. Global Immunohematology Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Blood-Related Diseases
  • HIV
  • Hepatitis
  • 6.4. Global Immunohematology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Pretransfusion Testing
  • Investigation Of Immune Hemolysis
  • Perinatal Testing
  • Blood Group Phenotyping
  • Leucocyte And Platelet Serology
  • 6.5. Global Immunohematology Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Blood Banks
  • Diagnostic And Reference Laboratories
  • Hospitals
  • Academic And Research Institutes
  • 6.6. Global Immunohematology Market, Sub-Segmentation Of Analyzers And Systems, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Blood Typing Analyzers
  • Cross-Matching Analyzers
  • Gel Card Systems
  • 6.7. Global Immunohematology Market, Sub-Segmentation Of Reagents, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Blood Grouping Reagents
  • Antisera
  • Control Serum

7. Immunohematology Market Regional And Country Analysis

  • 7.1. Global Immunohematology Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Immunohematology Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Immunohematology Market

  • 8.1. Asia-Pacific Immunohematology Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Immunohematology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Immunohematology Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Immunohematology Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Immunohematology Market

  • 9.1. China Immunohematology Market Overview
  • 9.2. China Immunohematology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Immunohematology Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Immunohematology Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Immunohematology Market

  • 10.1. India Immunohematology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Immunohematology Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Immunohematology Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Immunohematology Market

  • 11.1. Japan Immunohematology Market Overview
  • 11.2. Japan Immunohematology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Immunohematology Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Immunohematology Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Immunohematology Market

  • 12.1. Australia Immunohematology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Immunohematology Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Immunohematology Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Immunohematology Market

  • 13.1. Indonesia Immunohematology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Immunohematology Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Immunohematology Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Immunohematology Market

  • 14.1. South Korea Immunohematology Market Overview
  • 14.2. South Korea Immunohematology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Immunohematology Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Immunohematology Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Immunohematology Market

  • 15.1. Western Europe Immunohematology Market Overview
  • 15.2. Western Europe Immunohematology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Immunohematology Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Immunohematology Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Immunohematology Market

  • 16.1. UK Immunohematology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Immunohematology Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Immunohematology Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Immunohematology Market

  • 17.1. Germany Immunohematology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Immunohematology Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Immunohematology Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Immunohematology Market

  • 18.1. France Immunohematology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Immunohematology Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Immunohematology Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Immunohematology Market

  • 19.1. Italy Immunohematology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Immunohematology Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Immunohematology Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Immunohematology Market

  • 20.1. Spain Immunohematology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Immunohematology Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Immunohematology Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Immunohematology Market

  • 21.1. Eastern Europe Immunohematology Market Overview
  • 21.2. Eastern Europe Immunohematology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Immunohematology Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Immunohematology Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Immunohematology Market

  • 22.1. Russia Immunohematology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Immunohematology Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Immunohematology Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Immunohematology Market

  • 23.1. North America Immunohematology Market Overview
  • 23.2. North America Immunohematology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Immunohematology Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Immunohematology Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Immunohematology Market

  • 24.1. USA Immunohematology Market Overview
  • 24.2. USA Immunohematology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Immunohematology Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Immunohematology Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Immunohematology Market

  • 25.1. Canada Immunohematology Market Overview
  • 25.2. Canada Immunohematology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Immunohematology Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Immunohematology Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Immunohematology Market

  • 26.1. South America Immunohematology Market Overview
  • 26.2. South America Immunohematology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Immunohematology Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Immunohematology Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Immunohematology Market

  • 27.1. Brazil Immunohematology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Immunohematology Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Immunohematology Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Immunohematology Market

  • 28.1. Middle East Immunohematology Market Overview
  • 28.2. Middle East Immunohematology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Immunohematology Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Immunohematology Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Immunohematology Market

  • 29.1. Africa Immunohematology Market Overview
  • 29.2. Africa Immunohematology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Immunohematology Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Immunohematology Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Immunohematology Market Competitive Landscape And Company Profiles

  • 30.1. Immunohematology Market Competitive Landscape
  • 30.2. Immunohematology Market Company Profiles
    • 30.2.1. Ortho Clinical Diagnostics Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Immunocor Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Grifols S.A. Overview, Products and Services, Strategy and Financial Analysis

31. Immunohematology Market Other Major And Innovative Companies

  • 31.1. Beckman Coulter Inc.
  • 31.2. Thermo Fisher Scientific Inc.
  • 31.3. Becton Dickinson and Company
  • 31.4. Merck Co. & KGaA
  • 31.5. Bio-Rad Laboratories
  • 31.6. Sysmex Corporation
  • 31.7. Danaher Corporation
  • 31.8. Biosystems S.A.
  • 31.9. Roche Holdings AG
  • 31.10. Mindray Medical International Limited
  • 31.11. F.Hoffmann La-Roche Ltd.
  • 31.12. Biotest AG
  • 31.13. Cardinal Health Inc.
  • 31.14. Quotient Limited
  • 31.15. DiaSorin S.p.A.

32. Global Immunohematology Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Immunohematology Market

34. Recent Developments In The Immunohematology Market

35. Immunohematology Market High Potential Countries, Segments and Strategies

  • 35.1 Immunohematology Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Immunohematology Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Immunohematology Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer